Use of guinea pig data to obtain starting points for skin sensitisation risk assessment - A commentary

Regul Toxicol Pharmacol. 2024 Mar:148:105584. doi: 10.1016/j.yrtph.2024.105584. Epub 2024 Feb 28.

Abstract

The increasing drive to understand the likelihood of skin sensitisation from plant protection products (PPPs) in workers and the general public has resulted in recent initiatives to establish a quantitative risk assessment (QRA) methodology applicable to these products and their exposure scenarios. The effective evaluation of skin sensitising substances requires not only the identification of that toxicological hazard, but also determination of relative sensitising potency. Typically, this has been achieved by interpretation of local lymph node assay (LLNA) dose response data, delivering what is known as the EC3 value. This permitted regulatory division of skin sensitisers into defined potency sub-categories, but more importantly enabled derivation of a no expected sensitisation induction level (NESIL) as the point of departure for QRA. However, for many existing substances there is no LLNA data, only older guinea pig results exist. To avoid additional (in vivo) testing, an approach has been outlined to employ guinea pig data and existing regulatory guidelines on the determination of potency sub-categorisation to provide a guinea pig based NESIL. The approach adopts a conservative extrapolation from LLNA NESIL benchmarks to deliver points of departure as the basis for the type of QRA process already in successful use by other industries.

Keywords: Buehler test; Guinea pig maximisation test; Pesticides; Plant protection; Potency assessment; Regulatory guidelines; Risk assessment; Skin sensitisation.

MeSH terms

  • Allergens / toxicity
  • Animals
  • Dermatitis, Allergic Contact* / prevention & control
  • Guinea Pigs
  • Local Lymph Node Assay
  • Risk Assessment / methods
  • Skin

Substances

  • Allergens